1. Home
  2. ELDN vs HWBK Comparison

ELDN vs HWBK Comparison

Compare ELDN & HWBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELDN
  • HWBK
  • Stock Information
  • Founded
  • ELDN 2004
  • HWBK 1865
  • Country
  • ELDN United States
  • HWBK United States
  • Employees
  • ELDN N/A
  • HWBK N/A
  • Industry
  • ELDN Biotechnology: Pharmaceutical Preparations
  • HWBK Major Banks
  • Sector
  • ELDN Health Care
  • HWBK Finance
  • Exchange
  • ELDN Nasdaq
  • HWBK Nasdaq
  • Market Cap
  • ELDN 239.6M
  • HWBK 209.3M
  • IPO Year
  • ELDN N/A
  • HWBK N/A
  • Fundamental
  • Price
  • ELDN $4.34
  • HWBK $29.61
  • Analyst Decision
  • ELDN Strong Buy
  • HWBK
  • Analyst Count
  • ELDN 1
  • HWBK 0
  • Target Price
  • ELDN $16.00
  • HWBK N/A
  • AVG Volume (30 Days)
  • ELDN 553.2K
  • HWBK 9.1K
  • Earning Date
  • ELDN 11-12-2024
  • HWBK 01-28-2025
  • Dividend Yield
  • ELDN N/A
  • HWBK 2.54%
  • EPS Growth
  • ELDN N/A
  • HWBK N/A
  • EPS
  • ELDN N/A
  • HWBK 0.89
  • Revenue
  • ELDN N/A
  • HWBK $58,193,000.00
  • Revenue This Year
  • ELDN N/A
  • HWBK N/A
  • Revenue Next Year
  • ELDN N/A
  • HWBK N/A
  • P/E Ratio
  • ELDN N/A
  • HWBK $33.79
  • Revenue Growth
  • ELDN N/A
  • HWBK N/A
  • 52 Week Low
  • ELDN $1.43
  • HWBK $17.86
  • 52 Week High
  • ELDN $5.54
  • HWBK $34.00
  • Technical
  • Relative Strength Index (RSI)
  • ELDN 42.46
  • HWBK 47.20
  • Support Level
  • ELDN $4.32
  • HWBK $29.71
  • Resistance Level
  • ELDN $4.76
  • HWBK $31.82
  • Average True Range (ATR)
  • ELDN 0.39
  • HWBK 1.10
  • MACD
  • ELDN -0.09
  • HWBK -0.40
  • Stochastic Oscillator
  • ELDN 2.65
  • HWBK 10.23

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

About HWBK Hawthorn Bancshares Inc.

Hawthorn Bancshares Inc is a financial holding company and along with its subsidiary, it conducts general banking and trust business, offering its customers checking and savings accounts, internet banking, certificates of deposit, trust services, brokerage services, and safety deposit boxes. The company also offers a range of lending services, including commercial and industrial loans, single payment personal loans, installment loans, and commercial and residential real estate loans.

Share on Social Networks: